Why Experimental Setup Determines Off-target Data Quality
When people talk about gene editing safety, the focus is usually on detection: where are the off-targets? How many are there? Can we trust the data? However, many issues start much earlier within the experimental design. If the design isn’t right, the data won’t be either.
With INDUCE-seq® you’re not just measuring outcomes.
A lot of methods look at what’s left behind after editing; repair outcomes like indels and translocations. INDUCE-seq® looks directly at DNA breaks as they happen, providing a snapshot in time. Timing matters a lot more than people expect, if sampled too late, the breaks have been repaired, likewise too early, and they haven’t been induced yet.
The question isn’t just what you are measuring, it’s when you are measuring it.
There isn’t a “standard” setup
One of the most common things we see is reuse of the same experimental setups across different systems.
The right design depends on a few things all moving together:
How efficient the editing is
How it’s being delivered
What editing system is being used
What cells are being worked in
Change any one of those, and the timing can shift.
For example: RNPs behave very differently to plasmids, Cas9 isn’t Cas12a and iPSCs don’t behave like primary cells. Therefore, copying a setup from a previous experiment, even one that worked well can quietly set up the experiment for failure.
Timepoints are usually the make-or-break decision
INDUCE-seq® captures what’s happening at that exact moment, meaning that experiments need to land in the window where breaks are actively being formed. The easiest way to find that window is not to simply guess but to check.
By running a quick time course and measuring indel levels over time will highlight when editing ramps up and when it levels off. That ramp-up phase is where the break signal is. It’s a simple step, but it saves a lot of frustration later.
Controls aren’t just “good practice”, they’re what make the data usable
INDUCE-seq® will pick up all types of DNA breaks in the cell. Without proper controls, it can be guess-work to identify which are editing induced. At the very least the following controls are required:
A delivery-matched negative control at each timepoint
deally an untreated baseline as well
Beyond that, positive and assay controls help to sanity-check that everything’s behaving as expected. It might feel like extra work, but it’s what turns a dataset into something that is easier to interpret.
Replicates tell you more than you think
It’s easy to treat replicates as a box to tick, with INDUCE-seq®, they’re quite revealing. Because the workflow is PCR-free and quantitative, consistency across replicates is a clear signal of whether things are working properly.
Sample replicates → are things stable within the setup?
Biological replicates → are the breaks consistent across experiments, or just specific to that one run?
Including appropriate replicates isn’t optional. FDA guidance states that multiple biological replicates are expected for off-target nomination and confirmation for regulatory submission.
You can’t optimise everything, so decide what matters
Every experiment has trade-offs. More timepoints means a better understanding of editing kinetics. More replicates result in stronger confidence. More conditions allow for a broader comparison. However, all three can’t be maximized at once. The experimental design must be deliberate.
If guides are being screened, keep it simple, pick a good timepoint and prioritize throughput.
If moving towards lead selection or IND work, there’s a need to go deeper, so, more timepoints with better replication and in more relevant cells.
Different stages have a need for different priorities.
Most problems we see aren’t technical, they’re design-related
When experiments don’t work, it’s rarely because the assay failed, it’s usually:
Low levels of editing
Wrong timepoint
Missing controls
Insufficient number of replicates
A mismatch between the design and the biology
If these are well considered everything else becomes a lot easier.
Final thought
There isn’t a perfect template for designing these types of experiments, however, there is a common thread in the ones that work well. They’re thought through upfront and consider the biology seriously. They don’t try to shortcut the design stage and the data tends to speak for itself.
To read about INDUCE-seq® experimental design considerations in more detail, please check out our technical note